James Pomerantz - Publications

Affiliations: 
Rice University, Houston, TX 
Area:
Psychophysics
Website:
http://jamesrpomerantz.com/

21/320 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Pomerantz J, Chapman C, Flynn J, Noe C, Yingxue T. Parallelism is an emergent feature not derived from the detection of individual line slopes Journal of Vision. 17: 166. DOI: 10.1167/17.10.166  0.313
2016 Costa T, Orsten-Hooge K, go GR, Pomerantz J, Boggio P. Neural correlates of configural superiority and emergent features: an ERP study Journal of Vision. 16: 127-127. DOI: 10.1167/16.12.127  0.717
2016 Mestry N, Orsten-Hooge K, Pomerantz J, Donnelly N. Eye Movements Reveal the Competition between Basic and Configural Features in False Pop Out in Visual Search Journal of Vision. 16: 1163. DOI: 10.1167/16.12.1163  0.724
2015 Orsten-Hooge KD, Portillo MC, Pomerantz JR. False Pop Out. Journal of Experimental Psychology. Human Perception and Performance. PMID 26214500 DOI: 10.1037/xhp0000077  0.722
2015 Orsten-Hooge KD, Portillo MC, Pomerantz JR. False Pop Out Journal of Experimental Psychology: Human Perception and Performance. DOI: 10.1037/xhp0000077  0.674
2014 Pomerantz J, Quiang B, Austin A, Orsten K. Target Localization Responses Diagnose Emergent Features in Singleton Pop Out Journal of Vision. 14: 1046-1046. DOI: 10.1167/14.10.1046  0.34
2012 Hahn A, Cragin A, Pomerantz J. The role of perceptual features vs. learned associations in utilizing directional indicators F1000research. 12: 195-195. DOI: 10.7490/F1000Research.1090699.1  0.321
2012 Cragin A, Hahn A, Pomerantz J. Emergent Features Predict Grouping in Search and Classification Tasks Journal of Vision. 12: 431-431. DOI: 10.1167/12.9.431  0.39
2012 Pomerantz JR, Cragin AI, Orsten KD, Portillo MC. The computational and cortical bases for configural superiority Journal of Vision. 12: 1384-1384. DOI: 10.1167/12.9.1384  0.519
2011 Pomerantz JR, Portillo MC. Grouping and emergent features in vision: toward a theory of basic Gestalts. Journal of Experimental Psychology. Human Perception and Performance. 37: 1331-49. PMID 21728463 DOI: 10.1037/A0024330  0.619
2011 Orsten K, Portillo M, Pomerantz J. False pop-out in an odd quadrant visual search task F1000research. 2. DOI: 10.7490/F1000Research.1335.1  0.639
2011 Orsten K, Portillo MC, Pomerantz JR. False Pop Out in Visual Search Journal of Vision. 11: 1314-1314. DOI: 10.1167/11.11.1314  0.619
2011 Stupina A, Emert P, Pomerantz J. Emergent Features in two-line configurations prevent selective attention to individual lines as measured by Garner Interference Journal of Vision. 11: 1081-1081. DOI: 10.1167/11.11.1081  0.392
2010 Portillo M, Pomerantz J. Search asymmetries with emergent features Journal of Vision. 7: 911-911. DOI: 10.1167/7.9.911  0.656
2010 Portillo MC, Pomerantz JR. Evaluating grouping via emergent features: A systematic approach Journal of Vision. 5: 350-350. DOI: 10.1167/5.8.350  0.594
2010 Stupina A, Pomerantz J. Perceptual Organization based on Gestalts: Emergent Features in Two-Line Space Journal of Vision. 10: 1198-1198. DOI: 10.1167/10.7.1198  0.308
2003 Pomerantz JR, Agrawal A, Jewell SW, Jeong M, Khan H, Lozano SC. Contour grouping inside and outside of facial contexts. Acta Psychologica. 114: 245-71. PMID 14670700 DOI: 10.1016/J.Actpsy.2003.08.004  0.713
2002 Pomerantz JR, Agrawal A, Portillo MC. Contour grouping and the search for emergent features Journal of Vision. 2: 474a. DOI: 10.1167/2.7.474  0.637
1989 Pomerantz JR, Pristach EA. Emergent features, attention, and perceptual glue in visual form perception. Journal of Experimental Psychology. Human Perception and Performance. 15: 635-49. PMID 2531201  0.331
1973 Pomerantz JR, Garner WR. The role of configuration and target discriminability in a visual search task. Memory & Cognition. 1: 64-8. PMID 24214478 DOI: 10.3758/BF03198070  0.559
1973 Pomerantz JR, Garner WR. Stimules configuration in selective attention tasks Perception & Psychophysics. 14: 565-569. DOI: 10.3758/BF03211198  0.56
Low-probability matches (unlikely to be authored by this person)
2003 Pomerantz JR. Wholes, holes, and basic features in vision. Trends in Cognitive Sciences. 7: 471-3. PMID 14585437 DOI: 10.1016/j.tics.2003.09.007  0.296
2012 Pomerantz J, Cragin A. Crowding, Grouping, and the Configural Superiority Effect Journal of Vision. 12: 1286-1286. DOI: 10.1167/12.9.1286  0.293
2012 Orsten K, Pomerantz J. False Pop Out: Evidence of configural disruption in conventional pop out. Journal of Vision. 12: 1287-1287. DOI: 10.1167/12.9.1287  0.283
2006 Pomerantz JR. Colour as a Gestalt: Pop out with basic features and with conjunctions Visual Cognition. 14: 619-628. DOI: 10.1080/13506280500195052  0.277
2013 Cragin A, Ding B, Pomerantz J. Emergent Features Help Resolve Ambiguous Apparent Motion Journal of Vision. 13: 827-827. DOI: 10.1167/13.9.827  0.274
1977 Pomerantz JR, Sager LC, Stoever RJ. Perception of wholes and of their component parts: some configural superiority effects. Journal of Experimental Psychology. Human Perception and Performance. 3: 422-35. PMID 886276 DOI: 10.1037/0096-1523.3.3.422  0.271
1978 Martin RC, Pomerantz JR. Visual discrimination of texture. Perception & Psychophysics. 24: 420-8. PMID 745929 DOI: 10.3758/BF03199739  0.254
2008 Eidels A, Townsend JT, Pomerantz JR. Where similarity beats redundancy: the importance of context, higher order similarity, and response assignment. Journal of Experimental Psychology. Human Perception and Performance. 34: 1441-63. PMID 19045985 DOI: 10.1037/A0012320  0.247
2011 Pomerantz J, Stupina A, Sparck E. What's the "Point"? Assessing the Effectiveness of Stimuli that Indicate Direction Journal of Vision. 11: 1107-1107. DOI: 10.1167/11.11.1107  0.246
1983 Pomerantz JR. Global and local precedence: selective attention in form and motion perception. Journal of Experimental Psychology. General. 112: 516-40. PMID 6229597 DOI: 10.1037/0096-3445.112.4.516  0.24
2014 Orsten K, Pomerantz J. Is False Pop Out Really Pop Out? Evidence from RT functions. Journal of Vision. 14: 1077-1077. DOI: 10.1167/14.10.1077  0.227
1975 Pomerantz JR, Sager LC. Asymmetric integrality with dimensions of visual pattern Perception & Psychophysics. 18: 460-466. DOI: 10.3758/BF03204121  0.224
2013 Orsten K, Pomerantz J. False Pop Out and "Anti-metamers" Journal of Vision. 13: 828-828. DOI: 10.1167/13.9.828  0.206
1975 Pomerantz JR, Schwaitzberg SD. Grouping by proximity: Selective attention measures Perception & Psychophysics. 18: 355-361. DOI: 10.3758/BF03211212  0.204
1997 Lew H, Chmiel R, Jerger J, Pomerantz JR, Jerger S. Electrophysiologic indices of Stroop and Garner interference reveal linguistic influences on auditory and visual processing. Journal of the American Academy of Audiology. 8: 104-18. PMID 9101457  0.199
2012 Wagemans J, Feldman J, Gepshtein S, Kimchi R, Pomerantz JR, van der Helm PA, van Leeuwen C. A century of Gestalt psychology in visual perception: II. Conceptual and theoretical foundations. Psychological Bulletin. 138: 1218-52. PMID 22845750 DOI: 10.1037/A0029334  0.183
1992 Silverstein SM, Raulin ML, Pristach EA, Pomerantz JR. Perceptual organization and schizotypy. Journal of Abnormal Psychology. 101: 265-70. PMID 1583218 DOI: 10.1037/0021-843X.101.2.265  0.161
1980 POMERANTZ JR. Visual Cognition: The Way To See More Contemporary Psychology: a Journal of Reviews. 25: 685-686. DOI: 10.1037/019510  0.155
1977 Pomerantz JR. Pattern goodness and speed of encoding. Memory & Cognition. 5: 235-41. PMID 24202816 DOI: 10.3758/BF03197367  0.145
1984 Pomerantz JR, Toth N. Selective attention to aspects of motion configurations Acm Siggraph Computer Graphics. 18: 26-26. DOI: 10.1145/988525.988546  0.145
2006 Radford ML, Connaway LS, Pomerantz J. Shaping the future realities of virtual reference Proceedings of the Asist Annual Meeting. 43.  0.102
1969 Pomerantz JR, Kaplan S, Kaplan R. Satiation effects in the perception of single letters' Perception & Psychophysics. 6: 129-132. DOI: 10.3758/Bf03210077  0.101
1970 Pomerantz JR. Eye movements affect the perception of apparent (beta) movement Psychonomic Science. 19: 193-194. DOI: 10.3758/BF03328770  0.099
1982 Goldberg DM, Pomerantz JR. Models of illusory pausing and sticking. Journal of Experimental Psychology. Human Perception and Performance. 8: 547-61. PMID 6214607 DOI: 10.1037/0096-1523.8.4.547  0.097
2002 Pomerantz JM. The potential of selective norepinephrine reuptake inhibitors Drug Benefit Trends. 14: 21-22.  0.095
2002 Pomerantz JM. Editorial comment: Attention-deficit/hyperactivity disorder in adults Drug Benefit Trends. 14: 29.  0.093
1983 Pomerantz JR. Back to Basics in Sensation and Perception Contemporary Psychology: a Journal of Reviews. 28: 613-614. DOI: 10.1037/022235  0.092
1982 Pomerantz JR. The Intrigue of Perception Contemporary Psychology. 27: 353-354. DOI: 10.1037/021135  0.089
1977 Kosslyn SM, Pomerantz JR. Imagery, propositions, and the form of internal representations Cognitive Psychology. 9: 52-76. DOI: 10.1016/0010-0285(77)90004-4  0.082
2005 Pomerantz J. A linguistic analysis of question taxonomies Journal of the American Society For Information Science and Technology. 56: 715-728. DOI: 10.1002/Asi.20162  0.078
1981 Pomerantz JR, Goldberg DM, Golder PS, Tetewsky S. Subjective contours can facilitate performance in a reaction-time task. Perception & Psychophysics. 29: 605-11. PMID 7279591 DOI: 10.3758/BF03207379  0.074
2002 Pomerantz J. Question types in digital reference: An evaluation of question taxonomies Proceedings of the Acm International Conference On Digital Libraries. 404.  0.069
2016 Pomerantz J, Peek R. Fifty shades of open First Monday. 21. DOI: 10.5210/Fm.V21I5.6360  0.067
1978 Feldherr CM, Pomerantz J. Mechanism for the selection of nuclear polypeptides in Xenopus oocytes. The Journal of Cell Biology. 78: 168-75. PMID 566759 DOI: 10.1083/jcb.78.1.168  0.065
2009 Eidels A, Townsend JT, Pomerantz JR. "Where similarity beats redundancy: The importance of context, higher order similarity, and response assignment": Correction to Eidels, Townsend, and Pomerantz (2008). Journal of Experimental Psychology: Human Perception and Performance. 35: 169-169. DOI: 10.1037/A0014766  0.064
2014 Tamaki S, Nye C, Slorach E, Scharp D, Blau HM, Whiteley PE, Pomerantz JH. Simultaneous silencing of multiple RB and p53 pathway members induces cell cycle reentry in intact human pancreatic islets. Bmc Biotechnology. 14: 86. PMID 25305068 DOI: 10.1186/1472-6750-14-86  0.063
2006 Pomerantz J. Collaboration as the norm in reference work Reference and User Services Quarterly. 46: 45-55. DOI: 10.5860/Rusq.46N1.45  0.063
1994 Pomerantz JL, Sharp PA. Homeodomain determinants of major groove recognition. Biochemistry. 33: 10851-8. PMID 7916208 DOI: 10.1021/bi00202a001  0.062
1976 Pomerantz JR, Sager LC. Line-slope vs. line-arrangement discrimination: A comment on Ambler and Finklea's paper Perception & Psychophysics. 20: 220. DOI: 10.3758/BF03198605  0.061
2005 Pomerantz J. A conceptual framework and open research questions for chat-based reference service Journal of the American Society For Information Science and Technology. 56: 1288-1302. DOI: 10.1002/Asi.20215  0.059
1982 Zimmerman DE, Pomerantz JM, Sanfacon DG, Burger AW. Denture esthetics (III). Denture base color. Quintessence International, Dental Digest. 13: 747-58. PMID 6962451  0.056
2007 Pomerantz JM. Glutamate hypofunction and schizophrenia: A new theory Drug Benefit Trends. 19: 290-291.  0.056
2006 Pomerantz J. Google Scholar and 100 percent availabilty of information Information Technology and Libraries. 25: 52-56. DOI: 10.6017/Ital.V25I2.3331  0.054
2002 Pomerantz J, Lankes RD. Integrating expertise into the NSDL: Putting a human face on the digital library Proceedings of the Acm International Conference On Digital Libraries. 405.  0.054
2007 Pomerantz J, Marchionini G. The digital library as place Journal of Documentation. 63: 505-533. DOI: 10.1108/00220410710758995  0.054
2011 Blau HM, Pomerantz JH. Re"evolutionary" regenerative medicine. Jama. 305: 87-8. PMID 21177496 DOI: 10.1001/Jama.2010.1938  0.054
2007 Yang S, Wildemuth BM, Kim S, Murthy U, Pomerantz JP, Oh S, Fox EA. Further development of a digital library curriculum: Evaluation approaches and new tools Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 4822: 434-443.  0.053
2000 Pomerantz JM. Group psychotherapy: Managed care's missed opportunity Drug Benefit Trends. 12.  0.053
2008 Pomerantz JR. Overview of sensory processes Topics in Integrative Neuroscience: From Cells to Cognition. 359-362. DOI: 10.1017/CBO9780511541681.018  0.052
2001 Pomerantz J. Does the appendix serve a purpose in any animal? Scientific American. 285: 96. PMID 11681179  0.051
2010 Lamason RL, Lew SM, Pomerantz JL. Transcriptional target-based expression cloning of immunoregulatory molecules. Immunologic Research. 47: 172-8. PMID 20069388 DOI: 10.1007/S12026-009-8148-Z  0.051
2015 Makowski SL, Wang Z, Pomerantz JL. A protease-independent function for SPPL3 in NFAT activation. Molecular and Cellular Biology. 35: 451-67. PMID 25384971 DOI: 10.1128/MCB.01124-14  0.05
2015 Hesse RG, Kouklis GK, Ahituv N, Pomerantz JH. The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration. Elife. 4. PMID 26575287 DOI: 10.7554/Elife.07702  0.05
2012 Vallejo MC, Steen TL, Cobb BT, Phelps AL, Pomerantz JM, Orebaugh SL, Chelly JE. Efficacy of the bilateral ilioinguinal-iliohypogastric block with intrathecal morphine for postoperative cesarean delivery analgesia. Thescientificworldjournal. 2012: 107316. PMID 23304075 DOI: 10.1100/2012/107316  0.05
2007 Pomerantz JM. New generation of web tools connects as well as informs Drug Benefit Trends. 19: 251-252.  0.048
2005 Pomerantz JM. ADHD: More prevalent or better recognized? Drug Benefit Trends. 17: 220-221.  0.048
2010 Pomerantz JM. Initiatives increase for adoption of ACOs and PCMHs Drug Benefit Trends. 22: 149-152.  0.047
2009 Pomerantz JM. A new kind of prior authorization hassle Drug Benefit Trends. 21: 216-217.  0.047
2004 Pomerantz JM. New Business Tactic of Retrospective Reviews Leads to Reversal of Paid Claims Drug Benefit Trends. 16: 152-153.  0.046
2001 Pomerantz JM. Analyzing the terrorist mind Drug Benefit Trends. 13.  0.045
2015 Greene JA, Oswald CA, Pomerantz J. Predictors of Retention and Achievement in a Massive Open Online Course American Educational Research Journal. 52: 925-955. DOI: 10.3102/0002831215584621  0.045
1983 Pomerantz JR. The rubber pencil illusion. Perception & Psychophysics. 33: 365-8. PMID 6866698 DOI: 10.3758/BF03205883  0.044
2004 Pomerantz J. Factors influencing digital reference triage: A think-aloud study Library Quarterly. 74: 235-264. DOI: 10.1086/422765  0.044
2015 Balkin DM, Chen I, Oberoi S, Pomerantz JH. Bilateral Coronoidectomy by Craniofacial Approach for Hecht Syndrome-Related Trismus. The Journal of Craniofacial Surgery. 26: 1954-6. PMID 26335328 DOI: 10.1097/SCS.0000000000002014  0.044
2006 Pomerantz J, Luo L, McClure CR. Peer review of chat reference transcripts: Approaches and strategies Library and Information Science Research. 28: 24-48. DOI: 10.1016/J.Lisr.2005.11.004  0.044
2004 Pomerantz J, McClure CR. Evaluation of a statewide collaborative chat-based reference service: Approaches and directions Proceedings of the Asist Annual Meeting. 41: 102-109. DOI: 10.1002/meet.1450410112  0.043
1994 Pomerantz JM, Liptzin B, Carter AH, Perlman MS. The professional affiliation group: a new model for managed mental health care. Hospital & Community Psychiatry. 45: 308-10. PMID 8020912  0.043
2008 Pomerantz J, Haas SW, Hecht E. Identifying reusable resources in digital reference answers Proceedings of the Asist Annual Meeting. 45.  0.042
2011 Pomerantz J. Identifying reusable resources in digital reference responses Reference and User Services Quarterly. 50: 366-378. DOI: 10.5860/Rusq.50N4.366  0.04
2017 Oppenheimer D, Zaromb F, Pomerantz JR, Williams JC, Park YS. Improvement of writing skills during college: A multi-year cross-sectional and longitudinal study of undergraduate writing performance Assessing Writing. 32: 12-27. DOI: 10.1016/J.Asw.2016.11.001  0.04
2015 Pedersen SM, Chan W, Jattani RP, Mackie DS, Pomerantz JL. Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181. Molecular and Cellular Biology. PMID 26711259 DOI: 10.1128/MCB.00876-15  0.038
2008 Pomerantz J, Wildemuth BM, Oh S, Yang S, Fox EA. Evaluation of a curriculum for digital libraries Proceedings of the Acm International Conference On Digital Libraries. 462. DOI: 10.1145/1378889.1379007  0.037
2010 Lamason RL, Kupfer A, Pomerantz JL. The dynamic distribution of CARD11 at the immunological synapse is regulated by the inhibitory kinesin GAKIN. Molecular Cell. 40: 798-809. PMID 21145487 DOI: 10.1016/J.Molcel.2010.11.007  0.037
2007 Eberl MM, Watroba N, Reinhardt M, Pomerantz J, Serghany J, Broffman G, Fox CH, Mahoney MC, Edge SB. Linked claims and medical records for cancer case management : evaluation of mammography abnormalities. Cancer. 110: 518-24. PMID 17577210 DOI: 10.1002/cncr.22808  0.034
1998 Pomerantz JL, Wolfe SA, Pabo CO. Structure-based design of a dimeric zinc finger protein. Biochemistry. 37: 965-70. PMID 9467467 DOI: 10.1021/bi972464o  0.034
2006 Wehrman TS, Raab WJ, Casipit CL, Doyonnas R, Pomerantz JH, Blau HM. A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions. Proceedings of the National Academy of Sciences of the United States of America. 103: 19063-8. PMID 17148612 DOI: 10.1073/Pnas.0605218103  0.034
2007 Pomerantz JM. The nocebo effect Drug Benefit Trends. 19: 167-168.  0.034
2009 Palermo A, Doyonnas R, Bhutani N, Pomerantz J, Alkan O, Blau HM. Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 1431-40. PMID 19141533 DOI: 10.1096/Fj.08-122903  0.034
2009 Pomerantz JH, Mukherjee S, Palermo AT, Blau HM. Reprogramming to a muscle fate by fusion recapitulates differentiation. Journal of Cell Science. 122: 1045-53. PMID 19295131 DOI: 10.1242/Jcs.041376  0.033
2006 Pomerantz JM. Treating persons with schizophrenia after CATIE Drug Benefit Trends. 18: 269-270.  0.032
2009 Pomerantz JM. Genetic polymorphism and major depression: New theories Drug Benefit Trends. 21: 97-98.  0.032
2002 Pomerantz JM. Terrorism: A viral analogy Drug Benefit Trends. 14.  0.032
2004 Pomerantz JM. Screening for bipolar depression in the primary care setting Drug Benefit Trends. 16: 472-473.  0.031
2006 Pomerantz J, Stutzman F. Collaborative reference work in the blogosphere Reference Services Review. 34: 200-212. DOI: 10.1108/00907320610669443  0.031
2002 Wurtz NR, Pomerantz JL, Baltimore D, Dervan PB. Inhibition of DNA binding by NF-kappa B with pyrrole-imidazole polyamides. Biochemistry. 41: 7604-9. PMID 12056891 DOI: 10.1021/Bi020114I  0.03
2006 Pomerantz JM. What's driving up the costs of treating ADHD? Drug Benefit Trends. 18: 309-310.  0.03
2013 Chan W, Schaffer TB, Pomerantz JL. A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival. Molecular and Cellular Biology. 33: 429-43. PMID 23149938 DOI: 10.1128/MCB.00850-12  0.029
2006 Pomerantz JM. Dr Pomerantz responds [2] Psychiatric Times. 23: 103.  0.029
1998 Pomerantz J, Schreiber-Agus N, Liégeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell. 92: 713-23. PMID 9529248 DOI: 10.1016/S0092-8674(00)81400-2  0.029
2015 Xu X, Wilschut KJ, Kouklis G, Tian H, Hesse R, Garland C, Sbitany H, Hansen S, Seth R, Knott PD, Hoffman WY, Pomerantz JH. Human Satellite Cell Transplantation and Regeneration from Diverse Skeletal Muscles. Stem Cell Reports. 5: 419-34. PMID 26352798 DOI: 10.1016/j.stemcr.2015.07.016  0.029
2013 Pomerantz JH, Blau HM. Tumor suppressors: enhancers or suppressors of regeneration? Development (Cambridge, England). 140: 2502-12. PMID 23715544 DOI: 10.1242/Dev.084210  0.029
1983 Cotmore JM, Mingledorf EB, Pomerantz JM, Grasso JE. Removable partial denture survey: clinical practice today. The Journal of Prosthetic Dentistry. 49: 321-7. PMID 6341545  0.028
2008 Pajcini KV, Pomerantz JH, Alkan O, Doyonnas R, Blau HM. Myoblasts and macrophages share molecular components that contribute to cell-cell fusion. The Journal of Cell Biology. 180: 1005-19. PMID 18332221 DOI: 10.1083/Jcb.200707191  0.028
2002 Pomerantz JL, Baltimore D. Two pathways to NF-kappaB. Molecular Cell. 10: 693-5. PMID 12419209 DOI: 10.1016/S1097-2765(02)00697-4  0.028
2003 Pomerantz JM. Safety versus effectiveness of atypical antipsychotic medications Drug Benefit Trends. 15: 29-34.  0.028
2005 Pomerantz JM. Pay-for-performance could better align incentives in behavioral health care Drug Benefit Trends. 17: 127-128.  0.028
2014 Sano T, Shaeffer M, Vargas-Gonzalez L, Pomerantz J. High strain rate performance of pressureless sintered boron carbide Conference Proceedings of the Society For Experimental Mechanics Series. 1: 13-19. DOI: 10.1007/978-3-319-00771-7_2  0.028
2015 Oh S, Yang S, Pomerantz JP, Wildemuth BM, Fox EA. Results of a digital library curriculum field test International Journal On Digital Libraries. DOI: 10.1007/S00799-015-0151-5  0.028
2009 Wildemuth BM, Pomerantz JP, Oh S, Yang S, Fox EA. The variety of ways in which instructors implement a modular digital library curriculum Proceedings of the Acm/Ieee Joint Conference On Digital Libraries. 455. DOI: 10.1145/1555400.1555510  0.028
2008 Pomerantz JM. What's inside your medicine cabinet? Drug Benefit Trends. 20: 461-462.  0.028
2004 Pomerantz JM, Finkelstein SN, Berndt ER, Poret AW, Walker LE, Alber RC, Kadiyam V, Das M, Boss DT, Ebert TH. Prescriber intent, off-label usage, and early discontinuation of antidepressants: a retrospective physician survey and data analysis. The Journal of Clinical Psychiatry. 65: 395-404. PMID 15096080 DOI: 10.4088/Jcp.V65N0316  0.027
1995 Jiaan DB, Seftel AD, Fogarty J, Hampel N, Cruz W, Pomerantz J, Zuik M, Monnier VM. Age-related increase in an advanced glycation end product in penile tissue. World Journal of Urology. 13: 369-75. PMID 9116757 DOI: 10.1007/BF00191219  0.027
2011 Szeto GL, Pomerantz JL, Graham DR, Clements JE. Minocycline suppresses activation of nuclear factor of activated T cells 1 (NFAT1) in human CD4+ T cells. The Journal of Biological Chemistry. 286: 11275-82. PMID 21282105 DOI: 10.1074/Jbc.M110.210518  0.027
2007 Pomerantz JM. A new explanation of affective disorders Drug Benefit Trends. 19: 419-420.  0.027
2014 Pomerantz JR. The experience error and the perils of psychopsychology. Wiley Interdisciplinary Reviews. Cognitive Science. 5: 509-17. PMID 26308741 DOI: 10.1002/wcs.1302  0.026
2014 Pomerantz JR. The experience error and the perils of psychopsychology Wiley Interdisciplinary Reviews: Cognitive Science. 5: 509-517. DOI: 10.1002/wcs.1302  0.026
2006 Pomerantz JM. New agents target sleep disorders Drug Benefit Trends. 18: 207-208.  0.026
2007 Pomerantz JM. New tool available for assessing long-term clinical outcomes Drug Benefit Trends. 19: 42-43.  0.026
2006 Pomerantz J, Luo L. Motivations and uses: Evaluating virtual reference service from the users' perspective Library and Information Science Research. 28: 350-373. DOI: 10.1016/J.Lisr.2006.06.001  0.026
1992 Pomerantz JL, Kristie TM, Sharp PA. Recognition of the surface of a homeo domain protein. Genes & Development. 6: 2047-57. PMID 1358755 DOI: 10.1101/gad.6.11.2047  0.026
2010 Pajcini KV, Corbel SY, Sage J, Pomerantz JH, Blau HM. Transient inactivation of Rb and ARF yields regenerative cells from postmitotic mammalian muscle. Cell Stem Cell. 7: 198-213. PMID 20682446 DOI: 10.1016/J.Stem.2010.05.022  0.025
2005 Pomerantz JM. After the black box warning: Treating children and adolescents who have depression Drug Benefit Trends. 17: 183-184.  0.025
2003 Pomerantz JM. Typical versus atypical antipsychotic medications: Adherence needs better understanding Drug Benefit Trends. 15: 37.  0.025
2008 Radford ML, Connaway LS, Pomerantz J, Mon L, Janes J. E-valuating E-reference: Transforming digital reference through research and evaluation Proceedings of the Asist Annual Meeting. 45.  0.025
1977 Shwartz SP, Pomerantz JR, Egeth HE. State and process limitations in information processing: An additive factors analysis Journal of Experimental Psychology: Human Perception and Performance. 3: 402-410. DOI: 10.1037/0096-1523.3.3.402  0.025
2002 Pomerantz JM. Editorial comment: Claims data likely underestimates prevalence of treated depression Drug Benefit Trends. 14: 39.  0.025
2007 Wan DC, Pomerantz JH, Brunet LJ, Kim JB, Chou YF, Wu BM, Harland R, Blau HM, Longaker MT. Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation. The Journal of Biological Chemistry. 282: 26450-9. PMID 17609215 DOI: 10.1074/Jbc.M703282200  0.024
2012 Garland CB, Pomerantz JH. Regenerative strategies for craniofacial disorders. Frontiers in Physiology. 3: 453. PMID 23248598 DOI: 10.3389/fphys.2012.00453  0.024
2010 Sheeran T, Reilly CF, Raue PJ, Weinberger MI, Pomerantz J, Bruce ML. The PHQ-2 on OASIS-C: a new resource for identifying geriatric depression among home health patients. Home Healthcare Nurse. 28: 92-102; quiz 102-4. PMID 20147803 DOI: 10.1097/Nhh.0B013E3181Cb560F  0.023
2002 Pomerantz JL, Denny EM, Baltimore D. CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. The Embo Journal. 21: 5184-94. PMID 12356734 DOI: 10.1093/emboj/cdf505  0.023
2003 Pomerantz J. Believes Florida's licensure process is too complicated. Journal of the American Veterinary Medical Association. 222: 714. PMID 12675289  0.023
2007 Pomerantz JM. Varenicline: A new approach to smoking cessation Drug Benefit Trends. 19: 122-123.  0.023
2007 Griffiths JM, King DW, Pomerantz J, Tenopir C, D'Elia G, Aerni SE. Technical session on: The impact of the Internet on users Proceedings of the Asist Annual Meeting. 44.  0.022
2010 Lamason RL, McCully RR, Lew SM, Pomerantz JL. Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain. Biochemistry. 49: 8240-50. PMID 20799731 DOI: 10.1021/Bi101052D  0.022
1995 Pomerantz JL, Pabo CO, Sharp PA. Analysis of homeodomain function by structure-based design of a transcription factor. Proceedings of the National Academy of Sciences of the United States of America. 92: 9752-6. PMID 7568211 DOI: 10.1073/pnas.92.21.9752  0.022
2007 Pomerantz J. Evaluation of online reference services Bulletin of the American Society For Information Science and Technology. 34: 15-19.  0.022
2008 Pomerantz J, Mon L, McClure CR. Evaluating remote reference service: A practical guide to problems and solutions Portal. 8: 15-30.  0.022
2004 Pomerantz J, Blau HM. Nuclear reprogramming: a key to stem cell function in regenerative medicine. Nature Cell Biology. 6: 810-6. PMID 15340448 DOI: 10.1038/Ncb0904-810  0.021
2009 Oh S, Wildemuth BM, Pomerantz J, Yang S, Fox EA. Using a Wiki as a platform for formative evaluation Proceedings of the Asist Annual Meeting. 46. DOI: 10.1002/meet.2009.1450460393  0.021
2001 Pomerantz JM. Remarkable findings from brain imaging studies Drug Benefit Trends. 13.  0.021
2009 Pomerantz J, Abbas J, Mostafa J. Teaching digital library concepts using digital library applications International Journal On Digital Libraries. 10: 1-13. DOI: 10.1007/S00799-008-0049-6  0.021
2005 Pomerantz JM. Screening for depression in primary care Drug Benefit Trends. 17: 273-274.  0.021
1998 Sheiman SL, Pomerantz JD. Tube feeding in dementia: a controversial practice. The Journal of Nutrition, Health & Aging. 2: 184-9. PMID 10995064  0.021
2003 Pomerantz JM. Schizophrenia as a risk factor for diabetes Drug Benefit Trends. 15: 4-5.  0.02
2002 Pomerantz JM. Quality of life in schizophrenia and drug formulary restriction Drug Benefit Trends. 14: 32-34.  0.02
1995 Pomerantz JL, Sharp PA, Pabo CO. Structure-based design of transcription factors. Science (New York, N.Y.). 267: 93-6. PMID 7809612 DOI: 10.1126/science.7809612  0.02
2006 Pomerantz JM. Behavioral health matters: Changing pattern of mental health service favors primary care, medication use Drug Benefit Trends. 18: 652-653.  0.02
2005 Pomerantz JM. Delivering cost-effecting psychotherapy Drug Benefit Trends. 17: 411-412.  0.02
2011 Rajpa G, Pomerantz JM, Waters JH, Vallejo MC. In reply International Journal of Obstetric Anesthesia. 20: 361. DOI: 10.1016/j.ijoa.2011.05.002  0.02
2004 Pomerantz JM. Internet prescriptions: Risky business for physicians and patients alike Drug Benefit Trends. 16: 202-203.  0.019
2002 Pomerantz JM. Are statins linked to impulsive anger? Drug Benefit Trends. 14: 37-38.  0.019
2007 Pomerantz JM. New developments in understanding and managing tardive dyskinesia Drug Benefit Trends. 19: 333-334.  0.019
2008 Pomerantz JM. Schizophrenia and the need to improve cognition Drug Benefit Trends. 20: 331-332.  0.018
2008 Pomerantz JM. New insight into drug addiction and self-control Drug Benefit Trends. 20: 248-250.  0.018
2001 Pomerantz JM. Is there a cost offset in treating the depression of high-utilizing medical patients? (Part 1 - Recent studies) Drug Benefit Trends. 13.  0.018
2007 Zhang F, Pomerantz JH, Sen G, Palermo AT, Blau HM. Active tissue-specific DNA demethylation conferred by somatic cell nuclei in stable heterokaryons. Proceedings of the National Academy of Sciences of the United States of America. 104: 4395-400. PMID 17360535 DOI: 10.1073/Pnas.0700181104  0.018
2000 Pomerantz JM. The art of persuading patients to take medication Drug Benefit Trends. 12.  0.017
2006 Pomerantz JM. New insights on causes and management of fibromyalgia Drug Benefit Trends. 18: 63-64.  0.017
2008 Pomerantz JR. Topics in integrative neuroscience: From cells to cognition Topics in Integrative Neuroscience: From Cells to Cognition. 1-442. DOI: 10.1017/CBO9780511541681  0.017
2007 Pomerantz JM. Selegiline patch is effective second-line therapy for depression Drug Benefit Trends. 19: 206-207.  0.017
1961 Pomerantz J. The influence of the absorption of radiation in shock tube phenomena Journal of Quantitative Spectroscopy and Radiative Transfer. 1: 185-248.  0.017
2009 Yang HC, Shen L, Siliciano RF, Pomerantz JL. Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation. Proceedings of the National Academy of Sciences of the United States of America. 106: 6321-6. PMID 19336585 DOI: 10.1073/Pnas.0809536106  0.017
2004 Pomerantz JM. Adherence to antipsychotic medication remains a sticky issue Drug Benefit Trends. 16: 368-369.  0.017
2000 Pomerantz JM. An emerging role for nicotine in the treatment of depression Drug Benefit Trends. 12.  0.016
2010 Pomerantz JM. Update on coverage mandates for patients with autism Drug Benefit Trends. 22: 105-109.  0.016
2001 Pomerantz JM. The widespread utility of antidepressants Drug Benefit Trends. 13: 34-35.  0.016
1995 Kristie TM, Pomerantz JL, Twomey TC, Parent SA, Sharp PA. The cellular C1 factor of the herpes simplex virus enhancer complex is a family of polypeptides. The Journal of Biological Chemistry. 270: 4387-94. PMID 7876203 DOI: 10.1074/jbc.270.9.4387  0.016
2004 Pomerantz JM. Proposal for a rational formulary for antipsychotic medications Drug Benefit Trends. 16: 610-611.  0.015
2007 Pomerantz JM. Behavioral health matters: The value of E-prescribing when covering for a colleague Drug Benefit Trends. 19: 378-379.  0.015
2004 Pomerantz JM. Rethinking Managed Care's Approach to Bipolar Disorder Drug Benefit Trends. 16: 88-89.  0.015
2007 Pomerantz JM. Dosing psychotherapy: Still a work in progress Drug Benefit Trends. 19: 454-455.  0.015
2008 Mostafa J, Pomerantz J, Tibbo HR, McDonough J, Palmer C. Developing curriculum for digital libraries and digital curation education: reflections on synergies and divergencies Proceedings of the Asist Annual Meeting. 45.  0.015
2005 Sommer K, Guo B, Pomerantz JL, Bandaranayake AD, Moreno-García ME, Ovechkina YL, Rawlings DJ. Phosphorylation of the CARMA1 linker controls NF-kappaB activation. Immunity. 23: 561-74. PMID 16356855 DOI: 10.1016/j.immuni.2005.09.014  0.015
2009 Lori Eakin, Pomerantz J. Virtual reference, real money: Modeling costs in virtual reference services Portal. 9: 133-164. DOI: 10.1353/Pla.0.0035  0.015
2004 Pomerantz JM. New focus on physical symptoms of depression Drug Benefit Trends. 16: 33-34.  0.015
2010 Pomerantz JI, Toney SD, Hill ZJ. Care coaching: an alternative approach to managing comorbid depression. Professional Case Management. 15: 137-42; quiz 143-4. PMID 20467275 DOI: 10.1097/NCM.0b013e3181c00f0f  0.015
2004 Pomerantz JM. Improving medication adherence: A new marketing opportunity for the pharmaceutical industry Drug Benefit Trends. 16: 279-280.  0.014
2008 McCully RR, Pomerantz JL. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association. Molecular and Cellular Biology. 28: 5668-86. PMID 18625728 DOI: 10.1128/MCB.00418-08  0.014
1998 Chin L, Pomerantz J, DePinho RA. The INK4a/ARF tumor suppressor: one gene--two products--two pathways. Trends in Biochemical Sciences. 23: 291-6. PMID 9757829 DOI: 10.1016/S0968-0004(98)01236-5  0.014
2003 Pomerantz JM. Integrating behavioral health with primary care Drug Benefit Trends. 15: 34-35.  0.014
2009 Pomerantz JM. Treating chronic suicidality Drug Benefit Trends. 21: 197-198.  0.014
2005 Pomerantz JM. Weighing benefits and risks in managing ADHD Drug Benefit Trends. 17: 317-318.  0.014
2009 Pomerantz JM. Untreated chronic mental illness Drug Benefit Trends. 21: 359-360.  0.014
2002 Pomerantz JM. Combining psychotherapy with antidepressant medication Drug Benefit Trends. 14: 31-32.  0.014
2008 Pomerantz JR. Overview of neuroscience, choice and responsibility Topics in Integrative Neuroscience: From Cells to Cognition. xi. DOI: 10.1017/CBO9780511541681.002  0.014
2002 Pomerantz JM. Clinical responsibility and E-therapy Drug Benefit Trends. 14: 29-30.  0.014
2007 Pomerantz JM. Brain stimulation therapies offer new hope for treatment-resistant depression Psychiatric Times. 24: 14-15.  0.013
2006 Pomerantz JM. Measuring outcomes in clinical practice Drug Benefit Trends. 18: 506-507.  0.013
2009 Yang S, Wildemuth BM, Pomerantz JP, Oh S, Fox EA. Core topics in digital library education Handbook of Research On Digital Libraries: Design, Development, and Impact. 493-505. DOI: 10.4018/978-1-59904-879-6.ch051  0.013
1983 Pomerantz JR. The grass is always greener: an ecological analysis of an old aphorism. Perception. 12: 501-2. PMID 6672747  0.013
2000 Pomerantz JM. Managed care's treatment of chronic and relapsing patients Drug Benefit Trends. 12.  0.013
2003 Pomerantz JM. Electronic prescribing raises issues of confidentiality and control Drug Benefit Trends. 15: 17-18.  0.013
2008 Gruber RP, Weintraub J, Pomerantz J. Suture techniques for the nasal tip. Aesthetic Surgery Journal / the American Society For Aesthetic Plastic Surgery. 28: 92-100. PMID 19083512 DOI: 10.1016/j.asj.2007.10.004  0.013
2005 Pomerantz JM. Addressing the root causes of the so-called access problem Drug Benefit Trends. 17: 36-37.  0.013
2006 Pomerantz JM. Long-term use of benzodiazepines: Still an effective therapeutic option Drug Benefit Trends. 18: 411-412.  0.012
2006 Pomerantz JM. Treating major depression to remission: Early results from STAR*D Drug Benefit Trends. 18: 360-361.  0.012
1999 Pomerantz JL, Baltimore D. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. The Embo Journal. 18: 6694-704. PMID 10581243 DOI: 10.1093/emboj/18.23.6694  0.012
2007 Pomerantz JM. Pharmacological approaches to Alzheimer disease Drug Benefit Trends. 19: 495-496.  0.012
1995 Ernst AA, Pomerantz J, Nick TG, Limbaugh J, Landry M. Lidocaine via iontophoresis in laceration repair: a preliminary safety study. The American Journal of Emergency Medicine. 13: 17-20. PMID 7832946  0.012
1999 Orlow I, Rabbani F, Chin L, Pomerantz J, Ligeois N, Dudas M, Depinho R, Cordón-Cardó C. Involvement of the Ink4a gene (p16 and p19arf) in murine tumorigenesis. International Journal of Oncology. 15: 17-24. PMID 10375589 DOI: 10.3892/IJO.15.1.17  0.012
2010 Shah C, Pomerantz J. Evaluating and predicting answer quality in community QA Sigir 2010 Proceedings - 33rd Annual International Acm Sigir Conference On Research and Development in Information Retrieval. 411-418. DOI: 10.1145/1835449.1835518  0.012
2003 Pomerantz JM. Making a hard job harder Drug Benefit Trends. 15: 25-29.  0.011
2010 Pomerantz JM. Hyperparathyroidism resulting from lithium treatment remains underrecognized Drug Benefit Trends. 22: 62-63.  0.011
2011 Bruce ML, Sheeran T, Raue PJ, Reilly CF, Greenberg RL, Pomerantz JC, Meyers BS, Weinberger MI, Johnston CL. Depression care for patients at home (Depression CAREPATH): intervention development and implementation, part 1. Home Healthcare Nurse. 29: 416-26. PMID 21716043 DOI: 10.1097/Nhh.0B013E31821Fe9F7  0.011
1964 BURROWS S, HOSTEN EB, POMERANTZ J. LYMPHOSARCOMA OF THE UTERUS: REPORT OF A CASE. Obstetrics and Gynecology. 24: 468-70. PMID 14207351  0.011
2002 Pomerantz JM. Access issues in behavioral health care Drug Benefit Trends. 14: 33-34.  0.01
2009 Pomerantz JM. Behavioral approaches to overcoming PTSD Drug Benefit Trends. 21: 165-166.  0.01
1983 Craelius W, Tiberio A, Pomerantz J. Neurotrophic regulation of GABA receptors at a crayfish inhibitory synapse. Journal of Neurobiology. 14: 123-32. PMID 6302224 DOI: 10.1002/Neu.480140204  0.01
1989 Pomerantz JL, Mauxion F, Yoshida M, Greene WC, Sen R. A second sequence element located 3' to the NF-kappa B-binding site regulates IL-2 receptor-alpha gene induction. Journal of Immunology (Baltimore, Md. : 1950). 143: 4275-81. PMID 2687377  0.01
2016 Pomerantz J. Management of persistent obstructive sleep apnea after adenotonsillectomy Pediatric Annals. 45: e180-e183. DOI: 10.3928/00904481-20160329-01  0.01
2002 Pomerantz JM. Brain imaging reveals structure, function Drug Benefit Trends. 14: 26-27.  0.01
2015 Pomerantz J, Hank C, Sugimoto CR. The state of social media policies in higher education. Plos One. 10: e0127485. PMID 26017549 DOI: 10.1371/Journal.Pone.0127485  0.01
2011 Bruce ML, Raue PJ, Sheeran T, Reilly C, Pomerantz JC, Meyers BS, Weinberger MI, Zukowski D. Depression Care for Patients at Home (Depression CAREPATH): home care depression care management protocol, part 2. Home Healthcare Nurse. 29: 480-9. PMID 21881429 DOI: 10.1097/Nhh.0B013E318229D75B  0.01
2011 Rajpal G, Pomerantz JM, Ragni MV, Waters JH, Vallejo MC. The use of thromboelastography for the peripartum management of a patient with platelet storage pool disorder. International Journal of Obstetric Anesthesia. 20: 173-7. PMID 21168326 DOI: 10.1016/j.ijoa.2010.09.014  0.01
2010 Sacco A, Mourkioti F, Tran R, Choi J, Llewellyn M, Kraft P, Shkreli M, Delp S, Pomerantz JH, Artandi SE, Blau HM. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell. 143: 1059-71. PMID 21145579 DOI: 10.1016/J.Cell.2010.11.039  0.01
2009 Radford ML, Connaway LS, Pomerantz J, Oh S, Oh JS, Shah C, Gazan R. Opportunities, threats, & theoretical approaches: Research in traditional and social virtual reference quality Proceedings of the Asist Annual Meeting. 46. DOI: 10.1002/meet.2009.1450460117  0.01
2009 Pomerantz JM. Behavioral health matters: SSRIs and sexual dysfunction Drug Benefit Trends. 21: 326-327.  0.01
2009 Pomerantz JM. Atypical antipsychotics for treating major depression Drug Benefit Trends. 21: 244-245.  0.01
2009 Pomerantz JM. Behavioral health matters: Storytelling as a psychotherapeutic technique Drug Benefit Trends. 21: 294-295.  0.01
2009 Pomerantz JM. Surge in mental health conditions in war veterans Drug Benefit Trends. 21: 131-133.  0.01
2009 Pomerantz JM. Examining the link between obesity and mental illness Drug Benefit Trends. 21: 65-66.  0.01
2009 Pomerantz JM. Weighing the benefits of reformulated medications Drug Benefit Trends. 21: 29-30.  0.01
2009 Adams S, Cournoyer AJ, Guthrie R, Jayawant S, Medel M, Paul SH, Pollart SM, Pomerantz JM, Reissman DL, Sansgiry SS, Sonpavde G, Stern D, Sutton SS, Theodorou A, Valenti WM, et al. With appreciation for their time and effort Drug Benefit Trends. 21: 2.  0.01
2008 Pomerantz J, Choemprayong S, Eakin L. The Development and Impact of Digital Library Funding in the United States Advances in Librarianship. 31: 37-92. DOI: 10.1016/S0065-2830(08)31002-2  0.01
2008 Pomerantz JH, Blau H. Skeletal Muscle Stem Cells Principles of Regenerative Medicine. 386-397. DOI: 10.1016/B978-012369410-2.50023-1  0.01
2008 Pomerantz JM. Exploring the sleep-depression connection Drug Benefit Trends. 20: 500-502.  0.01
2008 Pomerantz JM. When does internet use become an addiction? Drug Benefit Trends. 20: 413-414.  0.01
2008 Pomerantz JM. A new appreciation of nursing home care Drug Benefit Trends. 20: 370-371.  0.01
2008 Pomerantz J. Digital (library services) and (digital library) services Journal of Digital Information. 9.  0.01
2008 Pomerantz JM. FDA warnings about suicidally: Balancing risk and benefit Drug Benefit Trends. 20: 149-150.  0.01
2008 Pomerantz JM. Early antidepressant treatment is effective for post-stroke depression Drug Benefit Trends. 20: 115-116.  0.01
2008 Pomerantz JM. Exercising away depression Drug Benefit Trends. 20: 73-74.  0.01
2008 Pomerantz JM. Second messenger systems, genes, neurogenesis, and mood disorders Psychiatric Times. 25: 69+70-71+72-73.  0.01
2008 Pomerantz JM. Exercise and cognition: What's the connection? Drug Benefit Trends. 20: 35-36.  0.01
2007 Pomerantz J, Oh S, Wildemuth BM, Yang S, Fox EA. Digital library education in computer science programs Proceedings of the Acm International Conference On Digital Libraries. 177-178. DOI: 10.1145/1255175.1255208  0.01
2007 Pomerantz JM. Risk versus benefit of benzodiazepines Psychiatric Times. 24: 22-26.  0.01
2007 Pomerantz JM. Psychosocial improvement seen after bariatric surgery Drug Benefit Trends. 19: 83-84.  0.01
2007 Pomerantz JM. Editorial comment: Cost alone should not spur an antipsychotic medication switch Drug Benefit Trends. 19: 34.  0.01
2006 Pomerantz J, Wildemuth BM, Yang S, Fox EA. Curriculum development for digital libraries Proceedings of the Acm/Ieee Joint Conference On Digital Libraries. 2006: 175-184. DOI: 10.1145/1141753.1141787  0.01
2006 Pomerantz J, Oh S, Yang S, Fox EA, Wildemuth BM. The core: Digital library education in library and information science programs D-Lib Magazine. 12. DOI: 10.1045/November2006-Pomerantz  0.01
2006 Pomerantz JM. Brain metabolic correlates of depression and recovery Psychiatric Times. 23: 64+68.  0.01
2006 Abbas J, Kim KS, Wildemuth BM, Choi Y, Mostafa J, Brancolini K, Pomerantz J, Clobridge A. Education for digital librarianship: Employers' needs and how they can be addressed Proceedings of the Asist Annual Meeting. 43.  0.01
2006 Pomerantz JM. Prescription drug co-pays and vulnerable populations: Problems and opportunities Psychiatric Times. 23: 9-14.  0.01
2006 Pomerantz JM. Solving the problem of the wandering patient Drug Benefit Trends. 18: 556-557.  0.01
2006 Pomerantz JM. Exploring the connection between depression and heart disease Drug Benefit Trends. 18: 468-469.  0.01
2006 Pomerantz JM. Can posttraumatic stress disorder be prevented? Psychiatric Times. 23: 10-15.  0.01
2006 Pomerantz JM. Causal role seen for proinflammatory cytokines in depression Drug Benefit Trends. 18: 128-129.  0.01
2006 Yang S, Fox EA, Wildemuth BM, Pomerantz J, Oh S. Interdisciplinary curriculum development for digital library education Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 4312: 61-70.  0.01
2005 Pomerantz J, Dutton JM. Platelet gel for endoscopic sinus surgery. The Annals of Otology, Rhinology, and Laryngology. 114: 699-704. PMID 16240933  0.01
2005 Palermo AT, Labarge MA, Doyonnas R, Pomerantz J, Blau HM. Bone marrow contribution to skeletal muscle: a physiological response to stress. Developmental Biology. 279: 336-44. PMID 15733662 DOI: 10.1016/J.Ydbio.2004.12.024  0.01
2005 Pomerantz JM. Medicare Part D and implications of the benzodiazepine exclusion Drug Benefit Trends. 17: 599-600.  0.01
2005 Pomerantz JM. Imaging techniques yield new insight into the neurobiology of addiction Drug Benefit Trends. 17: 545-546.  0.01
2005 Pomerantz JM. Behavioral health disorders and increased overall use of health resources: Is there a link? Drug Benefit Trends. 17: 483-484.  0.01
2005 Pomerantz JM. Eating disorders: When is medication use appropriate? Drug Benefit Trends. 17: 364-365.  0.01
2005 Pomerantz JM. Preventing post-traumatic stress disorder Drug Benefit Trends. 17: 81-82.  0.01
2004 Pomerantz JM. Recycling expensive medication: why not? Medgenmed : Medscape General Medicine. 6: 4. PMID 15266231  0.01
2004 Pomerantz JM. Neuroimaging opens window on biologic manifestations of depression and recovery Drug Benefit Trends. 16: 429-430.  0.01
2004 Pomerantz JM. Lithium treatment of bipolar disorder: Still the gold standard Drug Benefit Trends. 16: 325-326.  0.01
2003 Pomerantz JM. Massachusetts Medicaid officials pull back from restricting access to psychiatric medications Drug Benefit Trends. 15.  0.01
2003 Pomerantz JM. Antidepressants used as placebos: Is that good practice? Drug Benefit Trends. 15: 32-33.  0.01
2003 Pomerantz JM. Bipolar disorder: Time for a disease management approach? Drug Benefit Trends. 15: 28-29.  0.01
2003 Pomerantz JM. The relationship between psyhosis and poverty Drug Benefit Trends. 15: 31-32.  0.01
2003 Pomerantz JM. Off-label uses for atypical antipsychotic drugs in children Drug Benefit Trends. 15: 36-37.  0.01
2003 Pomerantz JM. Deliberate misdiagnoses of behavioral disorders: How widespread? Drug Benefit Trends. 15: 29-30.  0.01
2003 Pomerantz JM. Pramipexole as a psychiatric medication Drug Benefit Trends. 15: 25-26.  0.01
2003 Pomerantz JM. Treatment of the mentally ill in prisons and jails: Follow-up care needed Drug Benefit Trends. 15: 20-21.  0.01
2003 Pomerantz JM. SSRIs require thoughtful prescribing, careful monitoring Drug Benefit Trends. 15: 44-46.  0.01
2003 Pomerantz JM. No place to go: The mentally ill in jails and prisons Drug Benefit Trends. 15: 29-30.  0.01
2002 Pomerantz JM. Is there a shortage of psychiatrists? Psychiatric Services (Washington, D.C.). 53: 629. PMID 11986519 DOI: 10.1176/appi.ps.53.5.629  0.01
2002 Pomerantz JM. Patient noncompliance with medication: Antidepressants Drug Benefit Trends. 14: 22-23.  0.01
2002 Pomerantz JM. Ecstacy (MDMA): Is it safe? Drug Benefit Trends. 14: 42-43.  0.01
2002 Pomerantz JM. Diabetes mellitus and atypical antipsychotic drugs Drug Benefit Trends. 14: 39.  0.01
2002 Pomerantz JM. Is there a connection between subtle hypothyroidism and depression? Drug Benefit Trends. 14.  0.01
2002 Pomerantz JM. Is social phobia a serious medical disorder? Drug Benefit Trends. 14.  0.01
2002 Pomerantz JM. Viagra and medical necessity Drug Benefit Trends. 14.  0.01
2001 Pomerantz JM. The next 10 years in behavioral health service delivery (Part 1) Drug Benefit Trends. 13.  0.01
2001 Pomerantz JM. Antidepressants and breast cancer risk Drug Benefit Trends. 13.  0.01
2001 Pomerantz JM. Editorial comment: Applying knowledge from the substance abuse field to gambling addictions Drug Benefit Trends. 13.  0.01
2001 Pomerantz JM. Medical disease offset versus medical cost offset Drug Benefit Trends. 13: 22-23.  0.01
2001 Pomerantz JM. Omega-3 fatty acids and mental health Drug Benefit Trends. 13.  0.01
2001 Pomerantz JM. The diabetes and depression connection Drug Benefit Trends. 13.  0.01
2001 Pomerantz JM. The next 10 years in behavioral health service delivery (Part 2) Drug Benefit Trends. 13.  0.01
2001 Pomerantz JM. Medical disease offset: A case example Drug Benefit Trends. 13.  0.01
2000 Pomerantz JL, Baltimore D. Signal transduction. A cellular rescue team. Nature. 406: 26-7, 29. PMID 10894524 DOI: 10.1038/35017673  0.01
2000 Pomerantz JM. Will behavioral carveout management companies shift to disease management? Drug Benefit Trends. 12.  0.01
2000 Pomerantz JM. A case of inappropriate use of patient pharmacy data Drug Benefit Trends. 12.  0.01
2000 Pomerantz JM. Depression in the medically ill Drug Benefit Trends. 12.  0.01
2000 Pomerantz JM. Violence, behavioral health, and managed care Drug Benefit Trends. 12.  0.01
2000 Pomerantz JM. Antidepressants in primary care Drug Benefit Trends. 12.  0.01
2000 Pomerantz JM. Managed care and suicide prevention Drug Benefit Trends. 12.  0.01
2000 Pomerantz JM. Managed care gets free ride in Surgeon General's report on mental health Drug Benefit Trends. 12.  0.01
2000 Pomerantz JM. Patient-practitioner relationships in the age of information Drug Benefit Trends. 12.  0.01
1999 Pomerantz JM. The House of Managed Care. Medgenmed : Medscape General Medicine. E8. PMID 11104410 DOI: v01.n09/mgm0914.pome/mgm0914.pome-01  0.01
1999 Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner JW, Cordon-Cardo C, Yancopoulos GD, DePinho RA. Essential role for oncogenic Ras in tumour maintenance. Nature. 400: 468-72. PMID 10440378 DOI: 10.1038/22788  0.01
1998 Pomerantz JM. Mental health carve-outs. Health Affairs (Project Hope). 17: 243-4. PMID 9691568  0.01
1997 Chin L, Pomerantz J, Polsky D, Jacobson M, Cohen C, Cordon-Cardo C, Horner JW, DePinho RA. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes & Development. 11: 2822-34. PMID 9353252 DOI: 10.1101/Gad.11.21.2822  0.01
1996 Pomerantz JE, Li C, Nathanielsz PW, McDonald TJ. Corticotropin-releasing hormone-like axons in the adrenal glands of fetal and postnatal sheep. Journal of the Autonomic Nervous System. 59: 87-90. PMID 8816370  0.01
1996 Pomerantz JM. Managed care and mental health. The New England Journal of Medicine. 335: 57; author reply 57-. PMID 8637548  0.01
1995 Pomerantz JM. A managed care ethical credo: for clinicians only? Psychiatric Services (Washington, D.C.). 46: 329-30, 345. PMID 7788451  0.01
1995 Pomerantz JM. Managed care. The New England Journal of Medicine. 333: 1221. PMID 7565989  0.01
1994 Pomerantz JR. On criteria for ethics in science: Commentary on Rosenthal Psychological Science. 5: 135-136. DOI: 10.1111/j.1467-9280.1994.tb00647.x  0.01
1989 Pomerantz JR. Discerning Forms Behind the Curtain Contemporary Psychology: a Journal of Reviews. 34: 1008-1009. DOI: 10.1037/030734  0.01
1988 Rothenberg ME, Pomerantz JL, Owen WF, Avraham S, Soberman RJ, Austen KF, Stevens RL. Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor. The Journal of Biological Chemistry. 263: 13901-8. PMID 2458354  0.01
1982 Pomerantz JM, Sanfacon DG, Dougherty TP, Hanson S. Myxofibrosarcoma of the maxillary sinus. Delaware Medical Journal. 54: 147-52. PMID 7067862  0.01
1982 Pomerantz JM, Zimmerman DE. The use of nonparallel canine abutments for a tissue bar overdenture obturator. The Journal of Prosthetic Dentistry. 47: 194-7. PMID 7035656  0.01
1976 POMERANTZ JR. Where Hardware Meets Software Contemporary Psychology: a Journal of Reviews. 21: 274-275. DOI: 10.1037/015060  0.01
1971 Kolers PA, Pomerantz JR. Figural change in apparent motion. Journal of Experimental Psychology. 87: 99-108. PMID 5541564 DOI: 10.1037/h0030156  0.01
1971 Wasserman BH, Thompson RH, Geiger AM, Goodman SF, Pomerantz J, Turgeon LR, Beube FE. Relationship of occlusion and periodontal disease. II. Periodontal status of the study population. Journal of Periodontology. 42: 371-8. PMID 5282578 DOI: 10.1902/jop.1971.42.6.371  0.01
1971 Geiger AM, Wasserman BH, Thompson RH, Beube FE, Goodman SF, Pomerantz J, Turgeon LR. Relationship of occlusion and periodontal disease. I. A system for evaluating periodontal status. Journal of Periodontology. 42: 364-70. PMID 5282577 DOI: 10.1902/jop.1971.42.6.364  0.01
Hide low-probability matches.